Ronit Almog

Medicine & Life Sciences

1. Israel 100%
2. SARS Virus 58%
3. Colorectal Neoplasms 42%
4. Vaccines 31%
5. Population 28%
6. Crohn Disease 27%
7. Early Detection of Cancer 25%
8. Cohort Studies 25%
9. Antibodies 24%
10. USSR 23%
11. Odds Ratio 23%
12. Observational Studies 22%
13. Occult Blood 22%
14. Breast Neoplasms 21%
15. Health Personnel 21%
16. Tumor Necrosis Factor Inhibitors 21%
17. Prospective Studies 20%
18. Hematologic Tests 20%
19. Anti-Bacterial Agents 19%
20. Jews 19%
21. Mammography 18%
22. Case-Control Studies 18%
23. Confidence Intervals 18%
24. Acute Coronary Syndrome 17%
25. Neoplasms 17%
26. Vaccination 17%
27. Antibody Formation 17%
28. Respiratory Tract Infections 16%
29. Prescriptions 15%
30. Adalimumab 14%
31. Infections 14%
32. Longitudinal Studies 14%
33. Rheumatoid Arthritis 14%
34. secukinumab 14%
35. Placenta 13%
36. Body Mass Index 13%
37. tofacitinib 13%
38. Fetal Development 13%
39. Pharmaceutical Preparations 13%
40. Coronavirus 13%
41. Bacteriuria 13%
42. Erythrocyte Aggregation 13%
43. Therapeutics 12%
44. Myocardial Infarction 12%
45. Fetofetal Transfusion 12%
46. Hepatitis A Antibodies 12%
47. Infliximab 12%
48. Tumor Necrosis Factor-alpha 12%
49. Hydroxymethylglutaryl-CoA Reductase Inhibitors 12%
50. Occupational Groups 12%